5Grosso M, Traino A, Boni G, et al. Comparison of different thy- roid committed doses in radioiodine therapy for Graves' hyperthy- roidism. Cancer Biother Radiopharm, 2005,20(2):218-223.
6Markovic V, Eterovic D. Thyroid echogenicity predicts outcome of radioiodine therapy in patients with Graves" disease. J Clin En- cloerlnol Metah. 2007.92(9) : 3547-3552.
7Liang G, Zhong YY, Ying J. The significance of the thyroid vol- ume and the peak systolic velocity of superior thyroid blood flow as the predictors for early differentiation between temporary and permanent hypothyroidism followed by Iodine 131 treatment in Graves' disease. J Nucl Med, Meeting Abstract, 2008,49(Suppl 1):243.
8Collins J, Gough S. Autoimmunity in thyroid disease. Eur J NuclMed Mol Imaging, 2002,29(2) :$417 $424.
9Anonymous. Hyperthyroidism therapy: New hyperthyroidism therapy research has been reported by scientists at Cairo Uni- versity. Atlanta: Fitness and Wellness Business Week, 2008: 1464.
10Cappelli C, Candossi E, Castellano M, et al. Prognostic value of thyrotropin receptor antibodies (TRAb) in Graves' disease: a 120 months prospective study. Endocr J, 2007,54(5) : 713 720.
